Peptide supply chain: difference between revisions
Diff·revision 13 → 14·21:10, 22 Feb 2025
Difference between revision 13 and revision 14 of Peptide supply chain. 7 lines changed; the page grew by 135 bytes.
| Revision 13 — 04:26, 6 Feb 2025 IpamorelinIsold (talk) clarify that "cold chain" without a logger is a claim, not a record 5,181 bytes +1,005 | Revision 14 — 21:10, 22 Feb 2025 NPOV_Nadia (talk) alphabetise the see-also list 5,316 bytes +135 | ||
|---|---|---|---|
| 45 | <ref name="gmp">World Health Organization, ''Good Manufacturing Practices for Pharmaceutical Products: Main Principles'', WHO Technical Report Series. Sets out the stage-by-stage controls that unregulated supply is not obliged to operate.</ref> | 45 | <ref name="gmp">World Health Organization, ''Good Manufacturing Practices for Pharmaceutical Products: Main Principles'', WHO Technical Report Series. Sets out the stage-by-stage controls that unregulated supply is not obliged to operate.</ref> |
| 46 | 46 | ||
| + | 47 | == See also == | |
| + | 48 | * [[Lyophilisation]] | |
| + | 49 | * [[Cold chain]] | |
| + | 50 | * [[Temperature excursion]] | |
| + | 51 | * [[Certificate of analysis]] | |
| + | 52 | * [[Lot traceability]] | |
| + | 53 | ||
| 47 | {{DEFAULTSORT:Peptide supply chain}} | 54 | {{DEFAULTSORT:Peptide supply chain}} |
| 48 | [[Category:Peptide synthesis]] | 55 | [[Category:Peptide synthesis]] |